4th Quarter - Report

VIATRIS INC. for VIATRIS INC

Firm
Client
Income
—
Expenses
$410,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 3627/S. 1884, School Access to Emergency Epinephrine Act; S. 3187, Food and Drug Administration Safety and Innovation Act (FDASIA), Title 3, Generic Drug User Fee Amendment (GDUFA), Title 4, Fees Relating to Biosimilar Biological Products; Pharmaceutical Distribution Supply Chain; HIV/AIDS; Patent Settlements; Biosimilars; Electronic Distribution of Labeling of Prescription Drugs

LobbyistCovered position, as disclosed
DANIEL LUBOWITZ —
LARA RAMSBURG —
NIMISH SHAH New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3627 (112th), S. 1884 (112th), S. 3187 (112th)

Copyright/Patent/Trademark CPT

Patent settlements

LobbyistCovered position, as disclosed
LARA RAMSBURG —
NIMISH SHAH New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.